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Cross-linked pectin/high amylose mixtures were evaluated as a new excipient for matrix
tablets formulations, since the mixing of polymers and cross-linking reaction represent
rational tools to reach materials with modulated and specific properties that meet specific
therapeutic needs. Objective: In this work the influence of polymer ratio and cross-linking
process on the swelling and the mechanism driving the drug release from swellable matrix
tablets prepared with this excipient was investigated. Methods: Cross-linked samples were
characterized by their micromeritic properties (size and shape, density, angle of repose and
flow rate) and liquid uptake ability. Matrix tablets were evaluated according their physical
properties and the drug release rates and mechanisms were also investigated. Results:
Cross-linked samples demonstrated size homogeneity and irregular shape, with liquid
uptake ability insensible to pH. Cross-linking process of samples allowed the control of
drug release rates and the drug release mechanism was influenced by both polymer ratio
and cross-linking process. The drug release of samples with minor proportion of pectin
was driven by an anomalous transport and the increase of the pectin proportion contrib-
uted to the erosion of the matrix. Conclusion: The cross-linked mixtures of high amylose
and pectin showed a suitable excipient for slowing the drug release rates.
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The preparation of new materials for development of drug
delivery systems that allow the control of drug release rates
according to the specific therapeutic needs represents
an important subject of research in the pharmaceutical sci-
ences field.
The use of blends of already known polymers represents a
rational strategy to reach new materials with distinct prop-
erties that can be modulated according to specific uses [1e7],
avoiding the great majority of the costs involved in the syn-
thesis and characterization of a completely new material. In
this sense, simple changes in polymers ratio can result in a
wide range of physicochemical properties that may provide
different drug delivery patterns [2].
Hydrogels are hydrophilic polymers that absorb high
amounts of water and its increased use in the drug delivery
systems formulations is based on its ability to origin a gel
network in the swollen state which entraps the drug and acts
as a barrier to its release to the medium. In this way, the
swelling ability of hydrogels is a fundamental property that
should influence the drug release rates, by controlling both
the diffusion rate of the penetrant into the matrix and the
drug dissolution and diffusion throughout the gel layer of the
swollen matrix [8e12].
Starch is a natural polysaccharide composed by amylose,
representing the linear fraction of this macromolecule, while
amylopectin is highly branched fraction. High amylose, a
modified starch containing 70% of amylose, has been used
successfully in the research and development of swellable
hydrophilic matrices and many studies report their improved
properties for controlled drug delivery purposes in relation to
conventional starch [12e20].
Moreover, some properties of high amylose starch, such
as solubility, swelling, rheological behavior, gel and film
formation, and biodegradation rate can be modified via
esterification, etherification and oxidation of its hydroxyl
groups [12]. In fact, cross-linking has been shown to be a key
technique for modifying polysaccharides properties and can
be achieved by adding intra- and inter-molecular bonds
[21,22].
The successful use of high amylose starch cross-linked by
different chemicals, such as epichlorohydrin and sodium tri-
metaphosphate (STMP), for control of drug release rates in the
development of different controlled drug delivery systems
have been demonstrated [14,18,23e26]. High amylose cross-
linked with STMP at different degrees, by varying base
strength (2% or 4%) and contact time (0.5e4 h), was used as
excipient of solid non-compacted systems and according to
cross-linking degree the drug release rates were controlled
until 18 h [18].
Pectin is a polysaccharide that has been currently used,
modified or not, in the composition of hydrophilic matrices
and other drug delivery systems, since it is able to formmatrix
or reservoir systems and exhibits promising mucoadhesive
and swelling properties that may lead to an effective control
over drug delivery rate [27e33].
Blends of pectin and chitosan were used in preparation of
zincepectinechitosan composites intended to colon-specificdrug delivery of resveratrol and the colon-specific drug
release was reached [34].
In other work, blends of high amylose and pectin were
exploited for preparing microparticles that exhibited
increased encapsulation efficiency and decreased drug
dissolution in the simulated gastric condition (pH 1.2) in
relation to pectin-based microparticles [35].
The improvement of mechanical properties of dispersions
of blends of the conventional starch and pectin cross-linked
by STMP in relation to isolated polymer was also demon-
strated [36].
Blends of pectinehigh amylose starch cross-linked with
STMP in alkaline medium were early synthesized and char-
acterized by Carbinatto et al. (2012) [7] and the set of the results
shown that the cross-linking reaction allowed the building of
covalent gels with improved thermal and physical stability,
making this material a promising excipient for the design of
controlled drug release systems based on hydrogel matrices.
The drug release throughout the swellable polymer
matrices can be very complex and the understanding of the
differentmechanisms involved in this process is fundamental
for the rational design of drug delivery systems that can fulfill
the different therapeutic needs, by fitting the desired spatial
and time drug release schedules.
In this work, blends of high amylose and pectin cross-
linked with STPM at different degrees were evaluated as
excipient of hydrophilic matrix tablets and the influence of
cross-linking degree and polymers ratio on the drug release
patterns and mechanisms was evaluated.2. Materials and methods
2.1. Materials
Pectin (type LM-56CS) was provided from CP Kelco (Brazil),
high amylose (Hylon VII, 70% amylose, 30% amylopectin) was
obtained from National Starch & Chemical (New Jersey, USA),
STMP was purchased from SigmaeAldrich Co., (St. Louis,
USA), sodium hydroxide (NaOH) was supplied by Grupo Quı´-
mica (Brazil), hydrochloric acid was provided by Quimis
(Brazil), and nimesulide and sodium lauryl sulfate were from
Henrifarma (Sa˜o Paulo, Brazil).
2.2. Cross-linking of polymers
Cross-linking of polymers was performed according to pro-
cedure described in our previous paper [7].
Pectin and high amylose starch mixed at different mass
ratios (1:4, 1:1 and 4:1) were cross-linked with STMP (30% of
the polymer mass) at room temperature. Different degrees of
cross-linking were achieved by varying the base (NaOH) con-
centration (2% and 4%) and the pectin/high amylose starch/
NaOH/STMP contact time (1, 2 and 4 h). After the reaction
time, all samples were treated with the adequate amount of
1 mol/l HCl in order to set the pH at 6. The solids were sepa-
rated by vacuum filtration and washed repeatedly with
ethanol of different concentrations (85GL, 65GL and 96GL).
The final product was dried at room temperature for 24 h,
pulverized and sieved (sieve opening 0.97 mm). The samples
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high amylose)ebase strengthecross-linking reaction time;
samples without cross-linker received aW suffix as presented
in Table 1.
2.3. Size and shape properties
Size distribution analysis was performed by using a Motic Im-
ages Advance 3.2 image analyzer coupled to a Leica MZ APO
microscope. The parameters Feret diameter at 0 and circu-
larity of at least 100 particles were measured in order to
evaluate the particle size distribution and shape, respectively.
2.4. Liquid uptake
The dynamics of media uptake was determined on an Enslin’s
device [18,37]. For the assay, 0.05 g of powdered samples was
poured onto the sintering filter and the volume of media
absorbed by the sample after predetermined times was
measured with the graduated pipette of the device. Different
pH media were assayed in order to simulate the segments of
GI tract: 0.1 N hydrochloric acid, pH 2.0 and phosphate buffer
pH 7.4, all of them without enzymes. The assays were carried
out in triplicate and the results expressed as liquid uptake (%)
in relation to the initial mass of the samples. Statistical
analysis of the results was performed by ANOVA/Tukeywith a
significance level <0.05.
2.5. Bulk and tapped apparent densities
The bulk apparent density (db) and tapped apparent density
(dt) were indirectly evaluated from apparent volume (V) and
tapped volume (Vt) measurements. Initially, about 10 g (m) of
samples 11-4-2, 14-4-2, pectin and high amylose starch were
carefully introduced into a 25 ml graduated cylinder and the
bulk volume was measured. Thus, the samples were submit-
ted to cycles of 1250 taps on an automatic volumeter tester
(Volumeter Tapped, model SVM, ERWEKA, Heusenstamm,
Germany) until volume difference in relation to the previous
measurement was lesser than 2%. The values of db and dt were
calculated according to equations (1) and (2):
db ¼ mV (1)
dt ¼ mVt (2)Table 1 e Labeling of samples.
Concentration
NaOH
Mass ratios: pectin:high
amylose ratio
Reaction
time
4:1 1:1 1:4
2% 41-2-1 11-2-1 14-2-1 1 h
2% 41-2-2 11-2-2 14-2-2 2 h
2% 41-2-4 11-2-4 14-2-4 4 h
4% 41-4-1 11-4-1 14-4-1 1 h
4% 41-4-2 11-4-2 14-4-2 2 h
4% 41-4-4 11-4-4 14-4-4 4 h
4%a 41-4-4W 11-4-4W 14-4-4W 4 h
a Samples without cross-linker received a W suffix.2.6. Angle of repose and flow rate
The angle of reposewas determined according to the free base
cone technique [38]. An accurately weighed mass (20 g) of
samples 11-4-2, 14-4-2, pectin and high amylose starch was
introduced into a stainless steel funnel (1.2 cm opening)
coupled to a vibrating device. The orifice of the funnel was
opened and the powder flowed onto a flat surface. The cone
basis and height were measured and the a angle was calcu-
lated by equation (3). The time the whole powder mass spent
to flow down was measured in order to determining the flow
rate.
tga ¼ h
r
(3)
h ¼ cone height (cm) and r ¼ cone radius (cm).
2.7. Preparation of matrix tablets
The 11-4-2 and 14-4-2 samples were selected as carrier poly-
mer for tablets preparation, since according to rheological
data [7] and swelling properties, they was considered as the
most promising materials to control the drug release rates.
The tablets were produced in an eccentric tablet machine
(Erweka AR 400) equipped with a 10 mm flat punch and die
set that was manually filled with a mixture of polymer carrier
(250 mg) and nimesulide (100 mg), by applying sufficient
compression force to prepare tablets with hardness of 110 N.
Tablets containing carrier treated without cross-linker (with
W suffix) in the same proportion drug:carrier and drug raw
(100 mg) were also prepared under same conditions.
2.8. Physical properties of tablets
Physical properties of tablets were determined based on
pharmacopeial specifications [38]. Weight variation of 40
tablets was measured on an analytical balance (Owa Labor).
For the friability test, 20 tablets of each sample were submit-
ted to 100 revolutions in a friabilator (type TA 20 (Erweka)).
The hardness of 10 tablets of each sample was evaluated by
measuring the radial breaking force on a hardness tester
(Schleuniger Pharmatron e type 6D).
2.9. “In vitro” drug dissolution
The in vitro dissolution patterns of tablets containing 100 mg
of nimesulide and 250 mg of carrier polymer (11-4-2, 14-4-2,
11-4-2W, 14-4-2W) were performed on a Hanson Research
(New Hanson SR-8 Plus) dissolution station equipped with
apparatus I (basket), at 50 rpm. The dissolution tests were
performed in media with different pH values in order to
simulate the pH of different segments of GI tract, based on the
USP 31 [38] specifications for delayed release dosage forms
test, with minor modifications. The first step of the test was
performed in 750 ml of hydrochloric acid 0.1 N pH 2.0 (simu-
lated gastric media), during 120 min. Then, the pH was
changed to 7.4 (simulated small intestine fluid) by adding
250 ml of 0.2 M sodium phosphate tribasic. All media were
added by 0.5% sodium lauryl sulfate as surfactant due to the
low solubility of nimesulide in the gastric pH. The
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collected at pre-determined times. The drug concentration
was quantified by measuring the absorbance at 297 nm and
298 nm (Hewlett Packard-Kayak XA) in gastric and enteric
media, respectively. Tablets containing 100 mg of nimesulide
(drug raw) were tested as control.
2.10. Analysis of kinetic models
Drug dissolution data were fitted with different mathematical
models (Table 2) (Sigma Plot 10.0). All equations were fitted to
the whole dissolution curves, except for Peppas and Weibull
equations fitted only until 60% of data.3. Results and discussion
3.1. Particle size distribution
For all reaction conditions, the 4:1 and 1:1 samples presented
the narrowest size distribution (200e700 mm) while 1:4 sam-
ples reached 800 mm. However, the major size frequency of all
samples was observed in the 300e500 mm range. These similar
particle size features can be related to some homogeneity of
structures, so that when the stress is applied in comminution
process, the fissures are distributed in a somewhat homoge-
neous manner throughout the fragile points of polymer
network, avoiding the occurrence of particles with extreme
sizes [18]. In order to corroborate the size distribution data, the
Feret diameter of samples were determined and their values
were between 325.46 and 414.07 mm, confirming the size ho-
mogeneity of the particles. The circularity values between
0.599 and 0.746 demonstrate that the particles present irreg-
ular shape.
3.2. Liquid uptake
The swelling degree is an important property to be evaluated
in hydrophilic polymers used in controlled drug delivery sys-
tems because it is correlated with the diffusion rates of both
the penetrant into the matrix and the drug throughout the gel
layer of thematrix [8,20,31,39e41]. Besides, structural changes
due to cross-linking degree and the drug release behavior of
different materials can be evidenced by swelling behavior of
them [18].
The values of liquid uptake (%) in media with different pH
values (0.1 N HCl, phosphate buffer pH 7.4) are showed inTable 2 e Release mathematical models.
Model Equationa
Baker and Lonsdale 2/3[1  (1  (F/100))2/3]  (F/100) ¼ kBLt
First order F ¼ 100ð1 ek1tÞ
Higuchi F ¼ kH
ﬃﬃ
t
p
Hixson and Crowell F ¼ [1  (1  kHCt)]3
Peppas F ¼ kptn
Weibull F ¼ 1  exp(atb)
a F ¼ amount of drug release at time t; kBL, k1, kH, kHC and
kp¼ release rate constants for different equations; n and b¼ release
exponents.Fig. 1, in which it can be observed that samples prepared with
NaOH 2% presented higher swelling ability than samples
prepared with NaOH 4%. However, the swelling behavior of all
samples was not sensible to pH variation (p < 0.05).
The samples prepared with 2% NaOH at 4:1 polymer pro-
portion exhibited the highest swelling degree, since the most
hydrophilic polymer (pectin) is in greater proportion, favoring
the swelling [20,42]. The lower swelling ability of samples
prepared with 4% NaOH can be attributed to the high cross-
linking degree of these samples, such that the mesh size of
polymer network limits the water entrance in the polymer
structure. Besides, the inter-chains ester linkages of cross-
linked samples can restrict the motion of chains, affecting
the liquid diffusion throughout of them [18,25]. Additionally, it
should be evidenced that the samples 11-4-2 and 14-4-2,
which exhibited the lowest water uptake values were those
that presented the highest values of G0 (elastic modulus) [7],
findings that corroborate the achievements about the highest
cross-linking degree of these samples.
3.3. Apparent densities
The density of a powdered solid influences the flow, so that
denser powders present better flow properties [43,44]. The
values of bulk and packed densities ofmaterialswere between
0.5 and 0.8 g/ml (Table 3). According to values presented in
Table 3, the samples containing higher proportion of high
amylose showed lower density, certainly due to the low den-
sity of this polymer itself. The cross-linking process influ-
enced the density of 1:1 and 1:4 samples, promoting the
densification of them, which can be seen by their higher
density values in relation to the isolated polymers, since the
cross-linking process allow a more packed polymer network.
3.4. Flow properties
The angle of repose and the flow rate are parameters that
describe the flow ability of materials [43,45,46]. Pectin, 11-4-2
and 14-4-2 samples presented repose angles values between
20 and 30 (Table 3) while the high amylose value was 39.94.
The results of repose angle indicated that, generally, the
samples presented free flow behavior while the highest angle
value of high amylose demonstrates its flow deficiency [46].
The values of flow rate of pectin and high amylose were
2.542 and 0.491, respectively, while the cross-linked samples
values were 13.95 g/s (11-4-2) and 11.068 g/s (14-4-2). The
higher flow rate values of cross-linked samples confirm that
their higher densities favored the flow ability.
3.5. Physical properties of tablets
The values of weight variation, hardness and friability of
tablets were 2.57% and 1.66%, 118.7 N and 159.9 N and 0.12%
and 0.13% for samples 11-4-2 and 14-4-2, respectively.
The results of all physical parameters of tables are in
agreement with pharmacopeial specifications [38]. The low
weight variation of tablets (2.57% and 1.66% for 11-4-2 and 14-
4-2, respectively) is consistent with the free flow properties of
cross-linked samples that contribute to regular filling of die
and punch set.
Fig. 1 e Liquid uptake of samples 2% and 4% NaOH.
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The drug release from swellable hydrophilic matrices can be
controlled by physical and chemical process, involving the
liquid penetration within the polymer network, the swelling
of hydrated polymer, drug diffusion throughout swollen ma-
trix and, sometimes, its erosion [31,47].
The in vitro drug dissolution patterns from tablets are
showed in Fig. 2 and Table 4 shows that raw drug was fully
released in 1.5 h of test while the cross-linked samples 11-4-2
and 14-4-2 released 22.77% and 21.41%, respectively, in the
same time. The samples prepared without cross-linker (11-4-
2W and 14-4-2W) presented release rates about 1.3 times
faster than their cross-linked counterparts.
The lowest drug release rates exhibited by cross-linked
samples (11-4-2 and 14-4-2) demonstrate that the inter-
chains ester linkages introduced to the polymer structure by
cross-linking reaction should result in a more rigid structure,Table 3 e Values of flow rate, angle of repose, bulk and tapped
Pectin High am
Flow rate (g/s) 2.542  0.231 0.491 
Repose angle () 20.02  0.015 39.94 
db (g/ml) 0.607  0.004 0.502 
dt (g/ml) 0.769  0 0.588 which originates a more elastic and denser swollen matrix,
restricting the motion of chains [6,48,49]. This more viscous
physical barrier retards the drug diffusion and thus, the drug
release rates decrease.
In the acidic media, the lowest drug release (%) of 11-4-2
sample indicates that due to the higher pectin proportion
present in this sample, a more viscous and thicker gel layer
can be built, which represents a more resistant barrier against
drug diffusion [30,50].
However, in simulated enteric medium (pH 7.4), this sam-
ple exhibited the highest drug release rates, which can be
attributed to the increased solubility of pectin at this higher
pH value, making the drug release faster [27,35,51]. This
behavior is highlighted by 11-4-2W sample, since a sharp in-
crease of drug release rates also occurred in this higher pH.
Besides, in increased pH, the deprotonation and ionization
of sulfonanilide group of nimesulide enhance its solubility
[52], which can also favors the dissolution process.densities.
ylose 11-4-2 14-4-2
0.577 13.95  0.029 11.068  0.011
0.040 20.98  0 26.25  0
0.002 0.704  0 0.558  0.002
0 0.817  0.003 0.670  0.003
Fig. 2 e In vitro drug release profiles.
Table 4 e In vitro nimesulide released (%).
Samples Nimesulide released (%)
0.5 h 2 h 2.5 h 4 h
11-4-2 13.79 23.88 47.34 59.07
11-4-2W 17.97 36.11 95.88 100.20
14-4-2 9.02 26.47 38.77 51.88
14-4-2W 14.14 31.25 48.07 79.42
Table 6 e Correlation between release exponent (n)
values for the KorsmeyerePeppas equation and drug
release mechanisms depending on the geometry shape
[42].
Release exponent (n) Release
mechanismThin film Cylindrical Sphere
0.5 0.45 0.43 Fickian
diffusion
0.5 < n < 1.0 0.45 < n < 0.89 0.43 < n < 0.85 Anomalous
transport
1.0 0.89 0.85 Case II
transport
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The fitting of drug release data by appropriate mathematical
models that support the interpretation and comprehension of
the mechanisms involved in the control of drug release pro-
cess is a powerful tool to modulate the release features ac-
cording to specific therapeutic needs.
Different mathematical models (Table 2) were applied to
in vitro drug dissolution profiles and their respective co-
efficients were estimated (Table 5).
According to r2 values (Table 5) it can be noted that the 11-
4-2 and 14-4-2W samples fitted better with the Weibull modelTable 5 e Release coefficients for nimesulide fitted with differe
Release models
11-4-2
Baker and Lonsdale r2 0.8724
k 0.0004
Hixson and Crowell r2 0.9250
k 0.0013
Higuchi r2 0.8263
k 4.1734
First-order r2 0.8936
k 0.0044
Peppas r2 0.9664
k 0.4710
n 0.8800
Weibull r2 0.9872
k 136.3908
b 3.0144while the 14-4-2 and 11-4-2W samples do it with the Peppas
model.
The samples 14-4-2 and 11-4-2W fitted better with Peppas
model that is based on the Power Law, which establish an
exponential correlation between drug release and time; and it
must be fitted only to the first 60% of drug release [53e55].
For Peppas model, the value of release exponent (n) is
correlated with mechanism that drives the drug release pro-
cess and n release exponent values of studied samples pre-
sented between 0.4716 and 0.8628 (Table 5) that characterize
an anomalous transport for cylindrical shaped samples
(Table 6) [56].
The b coefficients values of the Weibull are correlated with
the releasemechanismof drug throughout the polymermatrix
(Table 6). Thus, values lower than 0.75 are related to Fickian
diffusion, while b values between 0.75 and 1.0 suggest that
release is governed by Fickian diffusion and case II transport
(swelling). The 11-4-2 and 14-4-2W samples presented b coef-
ficient values higher than 1 (Table 5). Therefore drug release is
driven by complexmechanism,where swelling plus erosion of
matrix and diffusion of drug take place concomitantly [45].
The samples 14-4-2 and 11-4-2W fitted better with Peppas
model and their respective release exponents (Table 5) indi-
cate that the release occurred according an anomalous
transport, in which this process is driven by both swelling of
matrix and diffusion of drug [56e61].
On the other hand, the release data of the samples 11-4-2
and 14-4-2W presented better correlation with the Weibullnt mathematical models.
Samples
14-4-2 11-4-2W 14-4-2W
0.8052 0.7018 0.8049
0.0003 0.0008 0.0006
0.9622 0.8560 0.9521
0.0010 0.0024 0.0016
0.8552 0.7787 0.8805
3.5891 5.8372 4.8173
0.9424 0.8185 0.9198
0.0036 0.0084 0.0058
0.9943 0.9946 0.9723
0.4673 3.7362 1.4487
0.8628 0.4716 0.6668
0.9931 0.9492 0.9945
35,726.536 102.9414 100.8062
1.2113 426,408.9007 10.2841
a s i a n j o u rn a l o f p h a rm a c e u t i c a l s c i e n c e s 9 ( 2 0 1 4 ) 2 7e3 4 33model and their respective b exponent values (Table 5) pointed
to a complex mechanism of drug release in which diffusion,
swelling and erosion of polymer matrix are involved in the
drug release process [57].
The change of drug release behavior of sample 11-4-2 in
relation to sample 14-4-2 can be attributed to the highest
pectin proportion in the former sample, since the more hy-
drophilic nature of this polymer must have contributed to an
effective dissolution of swollen polymer matrix, making the
erosion takes place in drug release process, accelerating the
drug release rates in the simulated enteric medium.
Moreover, the change of release mechanisms between 14-
4-2 and 14-4-2W samples also indicated that for samples
containing the lowest pectin proportion, the cross-linking
reaction allow the building of a more cohesive matrix, pre-
venting the erosion of the system.4. Conclusions
The blends of high amylose and pectin cross-linked with so-
dium trimetaphosphate shown to be a promising excipient for
swellable matrix tablets intended to controlled drug delivery
systems. Samples preparedwith 2% of base, containing higher
proportion of pectin, showed higher swelling ability, while for
samples prepared with 4% NaOH this property was limited by
the high cross-linking degree that restricts the motion of
polymer chains and decrease the size of polymer mesh. The
cross-linking reaction was an effective tool to control the drug
release rates and the mathematical models indicated that in-
crease of pectin proportion change the mechanism that drive
the drug release process, allowing the erosion of the system.
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